A Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies
Musculoskeletal disorders (MSDs) are among the most common cause for reduced work capacity and sick leave. Workplace health promotion programs are often neither tailored to the workplace nor the individual needs of the employees. To counteract lacking intersectional care, this four-year randomized c...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0acac065313c4d58be5062dd9ad1e8ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0acac065313c4d58be5062dd9ad1e8ee |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0acac065313c4d58be5062dd9ad1e8ee2021-11-25T17:48:52ZA Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies10.3390/ijerph1822118441660-46011661-7827https://doaj.org/article/0acac065313c4d58be5062dd9ad1e8ee2021-11-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/22/11844https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601Musculoskeletal disorders (MSDs) are among the most common cause for reduced work capacity and sick leave. Workplace health promotion programs are often neither tailored to the workplace nor the individual needs of the employees. To counteract lacking intersectional care, this four-year randomized controlled trial (RCT) aimed to investigate the effects of modular coordinating case management (treatment group) compared to supported self-management (control group) on MSD specific sick leave days (routine data), workability (WAI), self-efficacy (self-efficacy scale), and pain (German pain questionnaire, GPQ). The study network comprised 22 companies, 15 company health insurance funds, and 12 pension funds in Germany. Overall, 852 participants (Module A/early intervention: <i>n</i> = 651, Module B/rehabilitation: <i>n</i> = 190, Module C/reintegration: <i>n</i> = 10) participated. Both groups achieved fewer sick leave days, higher workability, and less pain (<i>p</i> < 0.0001) at follow-up compared to baseline. At follow-up, the coordinating case management group showed fewer disability days (GPQ), lower disability scores (GPQ), and lower pain intensities (GPQ) than the supported self-management group (<i>p</i> < 0.05), but no superiority regarding MSD specific sick leave days, workability, nor self-efficacy. Module A showed more comprehensive differences. The accompanying process evaluation shows barriers and facilitators for the implementation of the program, especially in a RCT setting.Kyung-Eun (Anna) ChoiLara LindertLara SchlomannChristina SamelMartin HellmichHolger PfaffMDPI AGarticleworkplace health promotionemployee healthsick leavereturn to workcase managementself-managementMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 11844, p 11844 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
workplace health promotion employee health sick leave return to work case management self-management Medicine R |
spellingShingle |
workplace health promotion employee health sick leave return to work case management self-management Medicine R Kyung-Eun (Anna) Choi Lara Lindert Lara Schlomann Christina Samel Martin Hellmich Holger Pfaff A Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies |
description |
Musculoskeletal disorders (MSDs) are among the most common cause for reduced work capacity and sick leave. Workplace health promotion programs are often neither tailored to the workplace nor the individual needs of the employees. To counteract lacking intersectional care, this four-year randomized controlled trial (RCT) aimed to investigate the effects of modular coordinating case management (treatment group) compared to supported self-management (control group) on MSD specific sick leave days (routine data), workability (WAI), self-efficacy (self-efficacy scale), and pain (German pain questionnaire, GPQ). The study network comprised 22 companies, 15 company health insurance funds, and 12 pension funds in Germany. Overall, 852 participants (Module A/early intervention: <i>n</i> = 651, Module B/rehabilitation: <i>n</i> = 190, Module C/reintegration: <i>n</i> = 10) participated. Both groups achieved fewer sick leave days, higher workability, and less pain (<i>p</i> < 0.0001) at follow-up compared to baseline. At follow-up, the coordinating case management group showed fewer disability days (GPQ), lower disability scores (GPQ), and lower pain intensities (GPQ) than the supported self-management group (<i>p</i> < 0.05), but no superiority regarding MSD specific sick leave days, workability, nor self-efficacy. Module A showed more comprehensive differences. The accompanying process evaluation shows barriers and facilitators for the implementation of the program, especially in a RCT setting. |
format |
article |
author |
Kyung-Eun (Anna) Choi Lara Lindert Lara Schlomann Christina Samel Martin Hellmich Holger Pfaff |
author_facet |
Kyung-Eun (Anna) Choi Lara Lindert Lara Schlomann Christina Samel Martin Hellmich Holger Pfaff |
author_sort |
Kyung-Eun (Anna) Choi |
title |
A Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies |
title_short |
A Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies |
title_full |
A Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies |
title_fullStr |
A Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies |
title_full_unstemmed |
A Cross-Provider Healthcare Management Program for Musculoskeletal Disorders: Results of a Randomized Controlled Trial in 22 German Companies |
title_sort |
cross-provider healthcare management program for musculoskeletal disorders: results of a randomized controlled trial in 22 german companies |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/0acac065313c4d58be5062dd9ad1e8ee |
work_keys_str_mv |
AT kyungeunannachoi acrossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT laralindert acrossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT laraschlomann acrossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT christinasamel acrossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT martinhellmich acrossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT holgerpfaff acrossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT kyungeunannachoi crossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT laralindert crossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT laraschlomann crossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT christinasamel crossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT martinhellmich crossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies AT holgerpfaff crossproviderhealthcaremanagementprogramformusculoskeletaldisordersresultsofarandomizedcontrolledtrialin22germancompanies |
_version_ |
1718411965679796224 |